IL218042A - Sustained release 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in multiple sclerosis
- Google Patents
Sustained release 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in multiple sclerosis
Info
Publication number
IL218042A
IL218042AIL218042AIL21804212AIL218042AIL 218042 AIL218042 AIL 218042AIL 218042 AIL218042 AIL 218042AIL 21804212 AIL21804212 AIL 21804212AIL 218042 AIL218042 AIL 218042A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2010/045211external-prioritypatent/WO2011019845A1/en
Application filed by Acorda Therapeutics IncfiledCriticalAcorda Therapeutics Inc
Publication of IL218042A0publicationCriticalpatent/IL218042A0/en
Publication of IL218042ApublicationCriticalpatent/IL218042A/en
Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions